Skip to main content

Table 2 Adjusted Hazard ratios for overall cohort and propensity score matched cohort using Cox proportional hazards model

From: Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm3

 

Overall cohort (n = 337)

Propensity score matched cohort ( n = 132)

………………… Hazard ratio (95 % CI)………………………

cART

Yes

0 · 22 (0 · 09, 0 · 52)

0 · 37 (0 · 15, 0 · 93)

No

1 · 0

1 · 0

Cotrimoxazole

Yes

0 · 03 (0 · 01, 0 · 15)

0 · 09 (0 · 02, 0 · 43)

No

1 · 0

1 · 0

TB cure

Yes

0 · 34 (0 · 16, 0 · 74)

0 · 28 (0 · 12, 0 · 68)

No

1 · 0

1 · 0